Money
RoboCT Secures Funding to Scale Consumer Exoskeleton Production
Hangzhou-based RoboCT has raised over ¥100 million in a Series B+ round to expand its exoskeleton business from clinical rehabilitation into the consumer mobility market.
October 16, 2026, 10:02 AM·TechNode
